Ifebemtinib

DB17570InvestigationalSmall molecule

Ifebemtinib: Overview.

Mechanism: Pharmacologically active on Focal adhesion kinase 1
Curator reviewed
Formula / weight: C₂₈H₂₈F₄N₆O₄ · 588.564 g/mol (avg)
Code names: BI-853520 · IN-10018

Resolves to

Compound

Structure

InChIKeyULMMVBPTWVRPSI-UHFFFAOYSA-NSMILESCOC1=C(NC2=NC=C(C(OC3=CC=CC4=C3C(=O)N(C)C4)=N2)C(F)(F)F)C=C(F)C(=C1)C(=O)NC1CCN(C)CC1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

18Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ifebemtinib, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.